Upstream Bio, Inc. revenue breakdown overview

Upstream Bio, Inc. revenue for the last year amounted to 2.37 M USD, the most of which — 2.38 M USD — came from its highest performing source at the moment, Treatments for Inflammatory Diseases, the year earlier bringing 1.21 M USD. The greatest contribution to the revenue figure was made by Japan — last year it brought Upstream Bio, Inc. 2.38 M USD, and the year before that — 1.21 M USD.